Fundraising FoxNanoligent
Barcelona, ES · 4 known investors
Find your way into Nanoligent
Sign up to see every warm intro you have to Nanoligent
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanoligent team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nanoligent is a biotech spin-off of the Universitat Autònoma de Barcelona and Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau that uses protein engineering and nanobiotechnology to develop targeted drug therapies, with a first cancer candidate targeting the CXCR4 receptor to limit tumor growth and metastasis. Its technology produces protein conjugates organized as nanoparticles for site-specific drug delivery aimed at oncology and potentially other disease biomarkers.
Founders & leadership
Investors · 4
How we know: i&i Biotech Fund's portfolio page · siliconcanals.com · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Nanoligent do?
- Nanoligent is a biotech spin-off of the Universitat Autònoma de Barcelona and Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau that uses protein engineering and nanobiotechnology to develop targeted drug therapies, with a first cancer candidate targeting the CXCR4 receptor to limit tumor growth and metastasis. Its technology produces protein conjugates organized as nanoparticles for site-specific drug delivery aimed at oncology and potentially other disease biomarkers.
- Who founded Nanoligent?
- Nanoligent was founded by Dr. A. Villaverde, Dr. E. Vázquez, Dr. R. Mangues, Dr. M. Rodríguez.
- Who are Nanoligent's investors?
- Nanoligent's investors include i&i Biotech Fund, Inveready Technology Investment Group, Italian Angels for Growth, Clave Capital.
- Where is Nanoligent headquartered?
- Nanoligent is headquartered in Barcelona, ES.